Filters

anti-PCSK9 control peptide Antibody

anti-PCSK9 control peptide Antibody size: 0,25 mg 413

Supplier ACR
Price 413
Size 0,25 mg
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Vial description NARC-1, NARC1roprotein convertase subtilisin/kexin type 9roprotein convertase PC9, Neural apoptosis-regulated convertase 1, Subtilisin/kexin-like protease PC9, PCSK-9
Categorycontrol peptide
Raised inlaboratory
Clone1 vial
Formpure
Reactivitynot determined
Puritypurified
Molecular weightin kDa
Sourcemammalian
Activityto be determined
Rangebroad
Protein numberQ8NBP7
Applicationnot determined
Storage Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4°
Description , Freeze thaw will destroy a percentage in every cycle and should be avoided, Isotype or positive controls by peptides, Peptides short amino acid chains or epitopes or blocking antagonists, The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, antibodies and deactivated samples, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4°
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24°
Gene targetPCSK9 peptide
Short nameanti-PCSK9 control peptide Antibody
Technique antibodies against human proteins, antibodies for, antibody to, peptides, Antibody
Alternative nameantibody to-proprotein convertase subtilisin/kexin classification 9 reference short protein sequence (Antibody to)
Alternative techniqueantibodies
Alternative to gene target Extracellular, PCSK9 and IDBG-99082 and ENSG00000169174 and 255738, Pcsk9 and IDBG-170186 and ENSMUSG00000044254 and 100102, this GO :0001822 and kidney development and biological process this GO :0001889 and liver development and biological process this GO :0001920 and negative regulation of receptor recycling and biological process this GO :0002092 and positive regulation of receptor internalization and biological process this GO :0004252 and serine-type endopeptidase activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005764 and lysosome and cellular component this GO :0005769 and early endosome and cellular component this GO :0005770 and late endosome and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005791 and rough endoplasmic reticulum and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006508 and proteolysis and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0006644 and phospholipid metabolic process and biological process this GO :0006915 and apoptotic process and biological process this GO :0007041 and lysosomal transport and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0009267 and cellular response to starvation and biological process this GO :0009986 and cell surface and cellular component this GO :0010469 and regulation of receptor activity and biological process this GO :0010989 and negative regulation of low-density lipoprotein particle clearance and biological process this GO :0016485 and protein processing and biological process this GO :0016540 and protein autoprocessing and biological process this GO :0019871 and sodium channel inhibitor activity and molecular function this GO :0022008 and neurogenesis and biological process this GO :0030134 and ER to this GO lgi transport vesicle and cellular component this GO :0030169 and low-density lipoprotein particle binding and molecular function this GO :0030182 and neuron differentiation and biological process this GO :0031232 and extrinsic component of external side of plasma membrane and cellular component this GO :0032799 and low-density lipoprotein receptor particle metabolic process and biological process this GO :0032802 and low-density lipoprotein particle receptor catabolic process and biological process this GO :0032803 and regulation of low-density lipoprotein particle receptor catabolic process and biological process this GO :0032869 and cellular response to insulin stimulus and biological process this GO :0034185 and apolipoprotein binding and molecular function this GO :0034189 and very-low-density lipoprotein particle binding and molecular function this GO :0034190 and apolipoprotein receptor binding and molecular function this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042632 and cholesterol homeostasis and biological process this GO :0043523 and regulation of neuron apoptotic process and biological process this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0043621 and protein self-association and molecular function this GO :0044822 and poly(A) RNA binding and molecular function this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0050750 and low-density lipoprotein particle receptor binding and molecular function this GO :0070326 and very-low-density lipoprotein particle receptor binding and molecular function, this GO :0004252: serine-type endopeptidase activity, this GO :0004252: serine-type endopeptidase activity and also this GO :0005515: protein binding and also this GO :0019871: sodium channel inhibitor activity and also this GO :0030169: low-density lipoprotein particle binding and also this GO :0034185: apolipoprotein binding and also this GO :0034189: very-low-density lipoprotein particle binding and also this GO :0034190: apolipoprotein receptor binding and also this GO :0043621: protein self-association and also this GO :0044822: poly(A) RNA binding and also this GO :0050750: low-density lipoprotein particle receptor binding and also this GO :0070326: very-low-density lipoprotein particle receptor binding, this GO :0005515: protein binding, this GO :0019871: sodium channel inhibitor activity, this GO :0030169: low-density lipoprotein particle binding, this GO :0034185: apolipoprotein binding, this GO :0034189: very-low-density lipoprotein particle binding, this GO :0034190: apolipoprotein receptor binding, this GO :0043621: protein self-association, this GO :0044822: poly(A) RNA binding, this GO :0050750: low-density lipoprotein particle receptor binding, this GO :0070326: very-low-density lipoprotein particle receptor binding, very-low-density lipoprotein particle receptor binding, proprotein convertase subtilisin/kexin type 9
Identity 20001
Gene PCSK9
Long gene name proprotein convertase subtilisin/kexin type 9
Synonyms gene HCHOLA3
Synonyms gene name autosomal dominant 3 , hypercholesterolemia
Synonyms NARC-1 FH3
Locus 1p32, 3
Discovery year 2003-05-13
GenBank acession AX207686
Entrez gene record 255738
Pubmed identfication 12552133 12730697
RefSeq identity NM_174936
Classification Proprotein convertase subtilisin/kexin family
Havana BLAST/BLAT OTTHUMG00000008136
Locus Specific Databases British Heart Foundation LRG_275

Similar products

Subscribe to our Newsletter